MENU
ADMA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

ADMA Biologics (ADMA) Ownership - Who owns ADMA Biologics?

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
465 State Route 17
Phone
+1 201 478-5552
Employees
647
Web
https://www.admabiologics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.97B
P/E Ratio
12.50
Total Cash
138.15M
Projected Growth
N/A
Total Debt
204.41M
Revenue
509.86M
Risk (Beta)
1.24
Dividend Yield
N/A
Total Cash/Share
0.60
Total Debt/Equity
N/A
Revenue/Share
2.09 USD as % of share price
View a ticker or compare two or three
ADMA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

an operator of a specialty immune globulin, development and commercialization of human plasma and plasma-derived therapeutics

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
465 State Route 17
Phone
+1 201 478-5552
Employees
647
Web
https://www.admabiologics.com